Mayer Davidson to Obesity
This is a "connection" page, showing publications Mayer Davidson has written about Obesity.
Connection Strength
0.552
-
Davidson MB, Navar MD, Echeverry D, Duran P. U-500 regular insulin: clinical experience and pharmacokinetics in obese, severely insulin-resistant type 2 diabetic patients. Diabetes Care. 2010 Feb; 33(2):281-3.
Score: 0.195
-
Ballani P, Tran MT, Navar MD, Davidson MB. Clinical experience with U-500 regular insulin in obese, markedly insulin-resistant type 2 diabetic patients. Diabetes Care. 2006 Nov; 29(11):2504-5.
Score: 0.158
-
Davidson MB. In adults with obesity without diabetes, adding tirzepatide to a lifestyle intervention increased weight loss at 72 wk. Ann Intern Med. 2022 10; 175(10):JC116.
Score: 0.119
-
Davidson MB. Diabetic retinopathy is not present in non-diabetic older overweight/obese African Americans. Diabetes Res Clin Pract. 2017 04; 126:322.
Score: 0.080